Gouty Arthritis
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent form before the trial-related activities, be able to understand the procedures and methods of the trial, and be willing to strictly abide by the clinical trial protocol to complete the trial; 2. Age between 18-75 years old, male or female; 3. Patients who meet the 1977 or 2015 ACR (American College of Rheumatology) classification and diagnosis criteria for gout, and have been identified by professional doctors as moderate to severe activity in the acute arthritis stage, and the TCM differentiates the disease as damp-heat accumulation type.
Exclusion criteria
Exclusion criteria: 1. Persons who are considered by researchers to have poor compliance and affect the evaluation of drug safety and effectiveness; persons who abuse drugs; 2. Patients with renal failure and liver damage (transaminase greater than three times the upper limit of normal); 3. Those who are allergic to various drugs in the program; 4. Patients with a history of chronic heart disease, malignant tumors, recurrent infectious diseases, peptic ulcers, and low blood levels; 5. Suffering from other diseases that may confuse gouty arthritis, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus, Sj?gren's syndrome and other diseases; 6. Pregnant women and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| interleukin-1ß;Cytokines IL-2, 4, 6, 10, TNF-a, IL-10, IFN-?;Uric acid;erythrocyte sedimentation rate;C-reactive protein; | — |
Countries
China
Contacts
The First Affiliated Hospital of Zhejiang Chinese Medical University